0001365618-14-000003.txt : 20140922
0001365618-14-000003.hdr.sgml : 20140922
20140922171917
ACCESSION NUMBER: 0001365618-14-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140918
FILED AS OF DATE: 20140922
DATE AS OF CHANGE: 20140922
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anacor Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001411158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 251854385
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1020 E. MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
BUSINESS PHONE: 650-543-7500
MAIL ADDRESS:
STREET 1: 1020 E. MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
FORMER COMPANY:
FORMER CONFORMED NAME: Anacor Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hove Anders D
CENTRAL INDEX KEY: 0001365618
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34973
FILM NUMBER: 141114617
MAIL ADDRESS:
STREET 1: 30 ROCKEFELLER PLAZA, SUITE 5508
CITY: NEW YORK
STATE: NY
ZIP: 10112
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2014-09-18
0001411158
Anacor Pharmaceuticals, Inc.
ANAC
0001365618
Hove Anders D
C/O VENROCK
3340 HILLVIEW AVE.
PALO ALTO
CA
94304
1
0
0
0
Common Stock
2014-09-18
4
S
0
1500
24.87
D
3484035
I
By Funds
Common Stock
2014-09-19
4
S
0
738500
24.87
D
2745535
I
By Funds
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Venrock Healthcare Capital Partners, L.P. ("VHCP"), VHCP Co-Investment Holdings, LLC ("VHCP Co-Invest"), Venrock Associates IV, L.P. ("VA4"), Venrock Partners, L.P. ("VP") and Venrock Entrepreneurs Fund IV, L.P. ("VEF4") on March 24, 2014.
VHCP holds an aggregate of 1,273,482 shares, VHCP Co-Invest holds an aggregate of 232,953 shares, VA4 hold an aggregate of 1,609,767 shares, VP holds an aggregate of 328,281 shares and VEF4 holds an aggregate of 39,552 shares.
VHCP Management, LLC ("VHCP Management") is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. Venrock Management IV, LLC ("VM4") is the sole general partner of VA4 and may be deemed to beneficially own these shares. Venrock Partners Management, LLC ("VPM") is the sole general partner of VP and may be deemed to beneficially own these shares. VEF Management IV, LLC ("VEFM4") is the sole general partner of VEF4 and may be deemed to beneficially own these shares. Dr. Hove is a managing member of VHCP Management and a member of VM4, VPM and VEFM4 and may be deemed to beneficially own these shares. Dr. Hove, VHCP Management, VM4, VPM and VEFM4 expressly disclaim beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein.
VHCP holds an aggregate of 1,003,546 shares, VHCP Co-Invest holds an aggregate of 183,575 shares, VA4 hold an aggregate of 1,268,550 shares, VP holds an aggregate of 258,696 shares and VEF4 holds an aggregate of 31,168 shares.
/s/ Anders D. Hove
2014-09-22